Obesity Epidemic and New GLP-1Drugs (Ozempic/Mounjaro).
The Best of 702 Weekend Breakfast - A podcast by 702 - Sundays
Categories:
Chief Clinical Officer at Discovery Health, Dr Noluthando Nematswerani on the effects of non-diabetic consumers abusing diabetes medicine like GLP-1Drugs (Ozempic/Mounjaro) for weight loss purposes. This after reports of supply shortages and ration how many injection pens filled with human insulin, for the treatment of diabetes.See omnystudio.com/listener for privacy information.
